TCL Archive NCI-supported meeting included tobacco industry representatives in dialogue on ethics. October 29, 2004
TCL Archive In Brief: WHI Revises Protocol After Study Finds High Rate Of Endometrial Hyperplasia January 27, 1995
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
